Neurology News

Level 4 comprehensive epilepsy program in Malaysia, a resource-limited country

1 Jan 2018

There is a great challenge to establish a level 4 epilepsy care offering complete evaluation for epilepsy surgery including invasive monitoring in a resource-limited country. This study aimed to report the setup of a level 4 comprehensive epilepsy program in Malaysia and the outcome of epilepsy surgery over the past 4 years. Level 4 epilepsy care has an important role and is possible with joint multidisciplinary effort in a middle-income country like Malaysia despite resource limitation.

The natural history of optic neuritis in Asian patients: An observational cohort study

1 Jan 2018

Optic neuritis, which may be a precursor to multiple sclerosis (MS), is an uncommon disease in Asian patients. The Asian Collaborative Longitudinal Optic Neuritis Epidemiology (ACLONE) is an observational cohort study that assessed the risk of recurrent optic neuritis and/or progression of further neurologic events, either MS or neuromyelitis optica (NMO) in Asian patients with firstever optic neuritis. Secondary aims were to study the presenting characteristics and visual outcome, and to identify risk factors for development of either MS or NMO.  Results confirm that the clinical characteristics of optic neuritis in Asian patients differ from classic optic neuritis.

Drug lowers deadly Huntington’s disease protein

11 Dec 2017

The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial led by UCL scientists. It successfully lowered the level of the harmful huntingtin protein in the nervous system.

Dementia: number of people affected to triple in next 30 years

7 Dec 2017

As the global population ages, the number of people living with dementia is expected to triple from 50 million to 152 million by 2050.

 

Middle-age spread raises the risk of dementia by up to a THIRD because it restricts blood flow

1 Dec 2017

A worldwide study of more than 1.3million people found those with a high body mass index (BMI) in their 50s were much more likely to develop the condition two decades later. The latest research, published in the journal Alzheimer's & Dementia, suggests that maintaining a healthy weight could prevent, or at least delay the devastating disease.

Neurologic Diseases Found to Be the Largest Cause of Disability Worldwide

16 Nov 2017

In an analysis of data for 195 countries, the Global Burden of Disorders Study Group found that neurological disorders caused 250.7 million disability-adjusted life years (DALYs) in 2015, an increase of 7.4 percent from 1990. Stroke was reported to be one of the leading causes of DALYs worldwide. Neurological diseases are the world’s largest cause of disability-adjusted life years (DALYs), or years of healthy life lost to due to death or disability, according to a systematic analysis performed for the Global Burden of Disease Study 2015, the most current overview of the way neurological diseases are affecting people around the world

Stroke Study Expands Window of Clot Removal Treatment for Some Patients

11 Nov 2017

Trial ended early after procedure demonstrates significant benefit. A procedure to remove clots from blocked brain vessels – known as thrombectomy - may be beneficial for some stroke patients even if they come in to the emergency room beyond the 6-hour treatment window that current guidelines endorse, according to a groundbreaking study conducted by an international team of physicians and researchers led by UPMC and Emory University. 

Effect of aerobic exercise on hippocampal volume in humans: A systematic review and meta-analysis

4 Nov 2017

Hippocampal volume increase in response to aerobic exercise has been consistently observed in animal models. However, the evidence from human studies is equivocal. In  this review to identify all controlled trials examining the effect of aerobic exercise on the hippocampal volumes in humans, it is found that aerobic exercise interventions may be useful for preventing age-related hippocampal deterioration and maintaining neuronal health.

Study shows how memories ripple through the brain

30 Oct 2017

NIH-funded study suggests increased communication between key brain areas during sleep. Using an innovative “NeuroGrid” technology, scientists showed that sleep boosts communication between two brain regions whose connection is critical for the formation of memories. 

World Stroke Day: 29th October 2017

25 Oct 2017

90% of strokes are linked to 10 risks we can all do something about. Take steps to prevent #stroke www.worldstrokecampaign.org  #WorldStrokeDay

People With Chronic Fatigue Syndrome Are Exhausted at a Cellular Level, Study Shows

24 Oct 2017

New research has found immune cells taken from the blood of volunteers diagnosed with CFS (chronic fatigue syndrome, sometimes also called myalgic encephalomyelitis, ME) show clear signs of low energy production, not only adding details to a complex and confusing condition, but demonstrating once again that it's not a disease that can be fixed with willpower alone.

Low risk of ICH after reperfusion therapy in acute stroke patients treated with direct oral anti-coagulant

16 Oct 2017

The safety of intravenous thrombolysis (IVT) and endovascular therapy (EVT) in patients treated with DOAC is unclear. According to the study, acute reperfusion therapy in acute ischemic stroke patients with DOAC may be safe. High systolic blood pressure, high glucose, and very recent treatment with DOAC may be risk factors for ICH after thrombolysis.

Posttraumatic dystonia

15 Oct 2017

In most cases the cause for dystonia is unknown. In a small number of patients, trauma precedes the onset of the dystonia. Significant head trauma is a well-recognized precipitating factor in dystonia. However, it has become increasingly recognized that peripheral trauma can also result in dystonia. Secondary dystonia resulting from both central and peripheral trauma, its possible pathogenesis and treatment is discussed in this review

FDA clears first 7T magnetic resonance imaging device

12 Oct 2017

Today, the U.S. Food and Drug Administration cleared the first seven tesla (7T) magnetic resonance imaging (MRI) device, more than doubling the static magnetic field strength available for use in the United States. The Magentom Terra is the first 7T MRI system cleared for clinical use in the United States.

Automating Brain MRI Image Quality Predictions

3 Oct 2017

Barriers in sharing and accessing data from neuroimaging has slowed progress in the field of neuroscience, even as newer technologies offer more promise. Now, scientists from Stanford University are tackling those issues through a new way of organizing brain-imaging data that simplifies data analysis and helps researchers collaborate more effectively – they call it BIDS (Brain Imaging Data Structure).

1 3